Literature DB >> 9122749

Immunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 human intervertebral discs.

M Kanemoto1, S Hukuda, Y Komiya, A Katsuura, J Nishioka.   

Abstract

STUDY
DESIGN: Immunohistologic staining of human intervertebral discs collected at the time of surgery (100 intervertebral discs from 80 patients) and 10 discs collected from 7 cadavers within 12 hours of death was performed using antimatrix metalloproteinase-3 monoclonal antibody and antitissue inhibitor of metalloproteinase-1 monoclonal antibody.
OBJECTIVES: To examine the relationship between matrix destruction and staining for matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in intervertebral disc degeneration. SUMMARY OF BACKGROUND DATA: Matrix metalloproteinase-3, which decomposes aggregating proteoglycans, has attracted research attention as a substance contributing to matrix destruction in the articular cartilage and intervertebral disc. However, except for a few in vitro studies, the relationship between matrix destruction of the intervertebral disc and matrix metalloproteinase-3 has been little studied.
METHODS: Immunohistologic staining was performed to examine the relationship between matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in the intervertebral disc, and the relationship of these two agents to magnetic resonance imaging, radiographic, and surgical findings.
RESULTS: Those cases testing positive for matrix metalloproteinase-3 and negative for tissue inhibitor of metalloproteinase-1 accounted for most of the surgical specimens. The matrix metalloproteinase-3-positive cell ratio was significantly correlated with the magnetic resonance imaging grade of intervertebral disc degeneration, and the matrix metalloproteinase-3-positive cell ratio observed in prolapsed lumbar intervertebral discs was significantly higher than that in nonprolapsed discs. In cervical intervertebral discs, the matrix metalloproteinase-3-positive cell ratio and staining of cartilaginous endplate were correlated with the size of osteophyte formation.
CONCLUSIONS: These findings suggested that intervertebral disc degeneration is caused by disturbance in the equilibrium of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1, and that matrix metalloproteinase-3 contributes to degeneration of the cartilaginous endplate.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9122749     DOI: 10.1097/00007632-199601010-00001

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  27 in total

1.  Expression and distribution of matrix metalloproteinases and their inhibitors in the human iris and ciliary body.

Authors:  J Lan; R K Kumar; N Di Girolamo; P McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2003-02       Impact factor: 4.638

2.  Vertebral body MRI related to lumbar fusion results.

Authors:  G R Buttermann; K B Heithoff; J W Ogilvie; E E Transfeldt; M Cohen
Journal:  Eur Spine J       Date:  1997       Impact factor: 3.134

3.  Tumor necrosis factor-α- and interleukin-1β-dependent matrix metalloproteinase-3 expression in nucleus pulposus cells requires cooperative signaling via syndecan 4 and mitogen-activated protein kinase-NF-κB axis: implications in inflammatory disc disease.

Authors:  Xin Wang; Hua Wang; Hao Yang; Jun Li; Qiqing Cai; Irving M Shapiro; Makarand V Risbud
Journal:  Am J Pathol       Date:  2014-07-22       Impact factor: 4.307

4.  Matrix metalloproteinase-7-dependent release of tumor necrosis factor-alpha in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

5.  Matrix metalloproteinase-3-dependent generation of a macrophage chemoattractant in a model of herniated disc resorption.

Authors:  H Haro; H C Crawford; B Fingleton; J R MacDougall; K Shinomiya; D M Spengler; L M Matrisian
Journal:  J Clin Invest       Date:  2000-01       Impact factor: 14.808

6.  SIRT1 inhibits apoptosis of degenerative human disc nucleus pulposus cells through activation of Akt pathway.

Authors:  DaWu Wang; ZhenMing Hu; Jie Hao; Bin He; Qiang Gan; XiaoMing Zhong; XiaoJun Zhang; JieLiang Shen; Ji Fang; Wei Jiang
Journal:  Age (Dordr)       Date:  2012-09-19

Review 7.  Biological treatment strategies for disc degeneration: potentials and shortcomings.

Authors:  Günther Paesold; Andreas G Nerlich; Norbert Boos
Journal:  Eur Spine J       Date:  2006-09-16       Impact factor: 3.134

8.  Biologic response of human intervertebral disc cells to gene therapy cocktail.

Authors:  Seong-Hwan Moon; Kotaro Nishida; Lars G Gilbertson; Hwan-Mo Lee; Hyang Kim; Ronald A Hall; Paul D Robbins; James D Kang
Journal:  Spine (Phila Pa 1976)       Date:  2008-08-01       Impact factor: 3.468

9.  Safety assessment of intradiscal gene therapy II: effect of dosing and vector choice.

Authors:  Eric A Levicoff; Joseph S Kim; Satoshi Sobajima; Corey J Wallach; James W Larson; Paul D Robbins; Xiao Xiao; Li Juan; Gianluca Vadala; Lars G Gilbertson; James D Kang
Journal:  Spine (Phila Pa 1976)       Date:  2008-06-15       Impact factor: 3.468

10.  Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc.

Authors:  Stephen M Richardson; Paul Doyle; Ben M Minogue; Kanna Gnanalingham; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2009-08-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.